As a member of Medicines Australia, Eisai Australia has undertaken to be open and transparent when we provide a reportable payment or transfer of value to a healthcare professional. Reportable payments or transfers of value are:
· Payments for the provision of services such as giving a lecture, chairing an educational meeting, providing advice as a member of an Advisory Board or as a Consultant
· Airfares, accommodation and/or conference registration fees to attend medical education as part of those services.
Eisai Australia has prepared the report for publication in accordance with the Medicines Australia Code of Conduct, Edition 18 and Australia’s Privacy legislation. The report identifies healthcare professionals by name where their consent has been provided. Where consent has not been provided the information is reported in aggregate.
From 1 October 2016, reporting these payments will be mandatory – details will be reported because healthcare professionals should reasonably expect that all reportable payments or transfers of value will be disclosed for each healthcare professional, by name. The report is designed to be read on this website. It is also provided as a downloadable CSV file. The report will be available for at least three years from date of publication.
To comply with our privacy obligations, the report may be amended from time to time. The report here contains the most up to date information. Any use or disclosure of the data by a third party is the responsibility of that third party, who must comply with the Australian Privacy Act 1988. For further information about the details in the report, please go to www.medicinesaustralia.com.au
From 30 August 2019, this information will now be held in a database, administered by Medicines Australia. This database is designed to be searchable as well as downloaded as a CSV file. For further information about the details in the report, or to search the database, please visit www.DisclosureAustralia.com.au
In addition to submitting its reports to Disclosure Australia, Eisai Australia Pty Ltd is publishing its report in CSV and PDF. Due to the nature of these reportable activities, which may include contracts spanning multiple reporting periods, there are some healthcare professionals who were contracted prior to the introduction of Medicines Australia’s database. This means these contracts did not include the now required statement informing of publication into a consolidated database. Therefore that data cannot be submitted to Disclosure Australia, and are instead included in the report published on this website. This issue has been resolved for future contracted activity and consent will be obtained for publication within the Medicines Australia's database.
Eisai is committed to maintaining transparency of its relationships with healthcare professionals and patient advocacy organisations.
Period 1 May 2019 to October 2019
Period 1 November 2018 to 30 April 2019
hhc helps to focus and motivate all of us who work here at Eisai, whether we are researching potential new medicines, conducting studies, working in manufacturing or informing healthcare professionals about our medicines.